The growth of a pioneering hypoglycemia-preventing kind 1 diabetes remedy has acquired $three.9m (£2.75m) in funding, it has been introduced. Zucara Therapeutics Inc. has been given the cash to additional its work on the modern ZT-01 drug, which is administrated as...